Shilpa Medicare Limited

As of June 30, 2026, Shilpa Medicare Limited carries a market capitalization of 117.07B, placing it among publicly traded companies globally. Its enterprise value stands at 117.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shilpa Medicare Limited's next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Shilpa Medicare Limited has 195.58M shares outstanding.

As of June 30, 2026, Shilpa Medicare Limited trades at a trailing price-to-earnings ratio of 39.04.

As of June 30, 2026, Shilpa Medicare Limited trades at an EV/EBITDA multiple of 23.86 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.96 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 30.67 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 117.07B versus a market cap of 117.07B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 16.58M in revenue per employee across its workforce of 1,015.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Shilpa Medicare Limited recorded 464.64M in income tax expense. That works out to an effective tax rate of 13.52, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.44B, leaving 2.97B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Shilpa Medicare Limited's stock has gained approximately 133.40% over the past 52 weeks. The 50-day moving average sits at 939.71, while the 200-day moving average is 565.69.

Over the twelve months ended June 30, 2026, Shilpa Medicare Limited generated 16.82B in revenue and converted that into 2.97B in net income, yielding earnings per share of 15.33. EBITDA reached 4.91B, while operating income came in at 3.70B.

Over the twelve months ended June 30, 2026, Shilpa Medicare Limited posted a gross margin of 69.33, reflecting its pricing power and cost economics. The operating margin of 21.96 and net profit margin of 17.67 provide insight into operational efficiency.

Shilpa Medicare Limited's most recent stock split took place on October 3, 2025 with a 1:2 split ratio.